Kudo, M. (2020). Better Efficacy of Ramucirumab in Japanese Patients than in the Global Population with Unresectable Hepatocellular Carcinoma. Liver Cancer.
Chicago Style CitationKudo, Masatoshi. "Better Efficacy of Ramucirumab in Japanese Patients Than in the Global Population With Unresectable Hepatocellular Carcinoma." Liver Cancer 2020.
Cita MLAKudo, Masatoshi. "Better Efficacy of Ramucirumab in Japanese Patients Than in the Global Population With Unresectable Hepatocellular Carcinoma." Liver Cancer 2020.
Atenció: Aquestes cites poden no estar 100% correctes.